Tennessee has joined a federal lawsuit in Connecticut against 20 generic drug manufacturers, alleging manipulation of prices.
State Attorney General Herbert Slatery’s office says in a release that the drugs treat diseases and conditions including basic infections, diabetes, cancer, epilepsy, multiple sclerosis and HIV.
The lawsuit alleges a conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. Tennessee is among 44 states joining in the lawsuit, along with Puerto Rico.
The release said the drugs account for billions of dollars of sales in the U.S. The lawsuit alleges the schemes affected the health insurance market, Medicare and Medicaid, and people who pay inflated prices.
One of the companies named in the suit, Teva Pharmaceuticals USA Inc., has denied any civil or criminal liability.
Topics Lawsuits
Was this article valuable?
Here are more articles you may enjoy.
Trump Demands $1 Billion From Harvard as Prolonged Standoff Appears to Deepen 
Insurance Broker Stocks Sink as AI App Sparks Disruption Fears 
Insurify Starts App With ChatGPT to Allow Consumers to Shop for Insurance 
What Analysts Are Saying About the 2026 P/C Insurance Market 
